Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Moderna, Inc. is undergoing a profound transformation as it navigates a post-pandemic landscape marked by mounting caution among investors.</li><li>After delivering record-breaking Covid-19 vaccine sales that propelled it into the spotlight during global crisis years, the biotech giant now faces significant headwinds.</li><li>Recent updates in financial performance and strategic repositioning have underscored a shift in outlook.</li></ul>

Moderna, Inc. is undergoing a profound transformation as it navigates a post-pandemic landscape marked by mounting caution among investors.After delivering record-breaking Covid-19 vaccine sales that propelled it into the spotlight during global crisis years, the biotech giant now faces significant headwinds.Recent updates in financial performance and strategic repositioning have underscored a shift in outlook.

Moderna In Crisis? A Possible Wake-Up Call That Investors Have Been Dreading!

<ul><li>Moderna, Inc. reported its financial results for the third quarter of 2024, highlighting key developments and challenges in its business operations.</li><li>The company delivered $1.9 billion in revenue, with a net income of $13 million, and ended the quarter with $9.2 billion in cash and investments.</li><li>This financial position underscores Moderna's robust liquidity, providing it with a solid foundation to support ongoing and future initiatives.</li></ul>

Moderna, Inc. reported its financial results for the third quarter of 2024, highlighting key developments and challenges in its business operations.The company delivered $1.9 billion in revenue, with a net income of $13 million, and ended the quarter with $9.2 billion in cash and investments.This financial position underscores Moderna's robust liquidity, providing it with a solid foundation to support ongoing and future initiatives.

Moderna Inc.: Expanding Global Presence For Unmatched Impact! - Major Drivers

Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

<ul><li>Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points and 1,454 points (10-day EMA).</li><li>Thailand's economy is expected to continue improving YoY in 4Q24E owing to the low base and the government's economic stimulus measures.</li><li>Therefore, we maintain our Trading Buy recommendation if the SET Index moves within the range of 1,393-1,455 points.</li></ul>

Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points and 1,454 points (10-day EMA).Thailand's economy is expected to continue improving YoY in 4Q24E owing to the low base and the government's economic stimulus measures.Therefore, we maintain our Trading Buy recommendation if the SET Index moves within the range of 1,393-1,455 points.

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Douglas Research Advisory

<ul>
<li>In this insight, we provide some of the main highlights of the book "The Real Anthony Fauci", which was written by Robert F. Kennedy Jr. (RFK Jr) in 2021.</li>
<li>We discuss how the appointment of RFK Jr could impact some of the major health care stocks in Korea, especially those that are involved in developing and producing vaccines.</li>
<li>Although the share prices of many Korean vaccines related stocks have declined materially in the past 2-3 years, RFK Jr becoming the next US Health Secretary could pose further headwinds.</li>
</ul>


In this insight, we provide some of the main highlights of the book "The Real Anthony Fauci", which was written by Robert F. Kennedy Jr. (RFK Jr) in 2021.
We discuss how the appointment of RFK Jr could impact some of the major health care stocks in Korea, especially those that are involved in developing and producing vaccines.
Although the share prices of many Korean vaccines related stocks have declined materially in the past 2-3 years, RFK Jr becoming the next US Health Secretary could pose further headwinds.


Appointment of RFK Jr as the US Health Secretary and a Book Review Of "The Real Anthony Fauci"

US-EU Index Rebalances / Quantitative Researcher

Dimitris Ioannidis

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Event-Driven

Monolithic Power Systems, Inc / Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/monolithic-power-systems-inc" target="_blank" data-smartkarma-citation="entities:2088:1" rel="noopener">Monolithic Power Systems (MPWR US)</a> is a direct addition followed by <a href="https://www.smartkarma.com/entities/applovin-corp" target="_blank" data-smartkarma-citation="entities:32989:1" rel="noopener">AppLovin (APP US)</a> which is a conditional addition but close to be direct. Demand is ~$1.8bn and ~3.5 ADV.</li>
<li>
<a href="https://www.smartkarma.com/entities/dollar-tree-inc" target="_blank" data-smartkarma-citation="entities:10913:1" rel="noopener">Dollar Tree Inc (DLTR US)</a> is a direct deletion with the highest exclusion probability as it is  ranked above the exit rank of 125. </li>
<li>
<a href="https://www.smartkarma.com/entities/super-micro-computer-inc" target="_blank" data-smartkarma-citation="entities:7921:1" rel="noopener">Super Micro Computer (SMCI US)</a> , <a href="https://www.smartkarma.com/entities/arm-holdings-inc" target="_blank" data-smartkarma-citation="entities:21816:1" rel="noopener">ARM Holdings (ARM US)</a> and <a href="https://www.smartkarma.com/entities/moderna-inc" target="_blank" data-smartkarma-citation="entities:28744:1" rel="noopener">Moderna (MRNA US)</a> are amongst the prioritized constituents preventing eligible candidates from entering the index. </li>
</ul>



Monolithic Power Systems (MPWR US) is a direct addition followed by AppLovin (APP US) which is a conditional addition but close to be direct. Demand is ~$1.8bn and ~3.5 ADV.

Dollar Tree Inc (DLTR US) is a direct deletion with the highest exclusion probability as it is  ranked above the exit rank of 125. 

Super Micro Computer (SMCI US) , ARM Holdings (ARM US) and Moderna (MRNA US) are amongst the prioritized constituents preventing eligible candidates from entering the index. 


Nasdaq-100 December 2024 Forecasts: Monolithic Power & AppLovin It; Dollar Tree Needs Watering

United States

Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Moderna (MRNA US)

Moderna In Crisis? A Possible Wake-Up Call That Investors Have Been Dreading!

Moderna, Inc. is undergoing a profound transformation as it navigates a post-pandemic landscape marked by mounting caution among investors. After...

Baptista Research

Moderna Inc.: Expanding Global Presence For Unmatched Impact! - Major Drivers

Moderna, Inc. reported its financial results for the third quarter of 2024, highlighting key developments and challenges in its business...

Baptista Research

TH 3Q24 GDP Growth & Weekly Strategy

Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points...

Krungthai XSpring

Appointment of RFK Jr as the US Health Secretary and a Book Review Of "The Real Anthony Fauci"

We provide some of the main highlights of the book "The Real Anthony Fauci." We also discuss the impact of appointment of RFK Jr as US Health...

Douglas Kim

Nasdaq-100 December 2024 Forecasts: Monolithic Power & AppLovin It; Dollar Tree Needs Watering

MPWR and APP are the top candidates for inclusion with an average forecasted demand at nearly $2bn and 3.5 ADV, while DLTR and ILMN face a high...

Dimitris Ioannidis

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Moderna In Crisis? A Possible Wake-Up Call That Investors Have Been Dreading!

Moderna, Inc. is undergoing a profound transformation as it navigates a post-pandemic landscape marked by mounting caution among investors. After...

Baptista Research

Moderna Inc.: Expanding Global Presence For Unmatched Impact! - Major Drivers

Moderna, Inc. reported its financial results for the third quarter of 2024, highlighting key developments and challenges in its business...

Baptista Research

TH 3Q24 GDP Growth & Weekly Strategy

Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points...

Krungthai XSpring

Appointment of RFK Jr as the US Health Secretary and a Book Review Of "The Real Anthony Fauci"

We provide some of the main highlights of the book "The Real Anthony Fauci." We also discuss the impact of appointment of RFK Jr as US Health...

Douglas Kim

Nasdaq-100 December 2024 Forecasts: Monolithic Power & AppLovin It; Dollar Tree Needs Watering

​MPWR and APP are the top candidates for inclusion with an average forecasted demand at nearly $2bn and 3.5 ADV, while DLTR and ILMN face a high...

Dimitris Ioannidis

MPWR and APP are the top candidates for inclusion with an average forecasted demand at nearly $2bn and 3.5 ADV, while DLTR and ILMN face a high...